Cargando…
Identification and Validation of MSX1 as a Key Candidate for Progestin Resistance in Endometrial Cancer
PURPOSE: Progestin resistance is a critical obstacle for endometrial conservative therapy. Therefore, studies to acquire a more comprehensive understanding of the mechanisms are urgent. However, the pivotal molecules are still unexplored. MATERIALS AND METHODS: We downloaded GSE121367 from the GEO d...
Autores principales: | Yang, Linlin, Cui, Yunxia, Huang, Ting, Sun, Xiao, Wang, Yudong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7679365/ https://www.ncbi.nlm.nih.gov/pubmed/33235459 http://dx.doi.org/10.2147/OTT.S271494 |
Ejemplares similares
-
Chlorpromazine Sensitizes Progestin-Resistant Endometrial Cancer Cells to MPA by Upregulating PRB
por: Cui, Yunxia, et al.
Publicado: (2021) -
Progestin Resistance and Corresponding Management of Abnormal Endometrial Hyperplasia and Endometrial Carcinoma
por: Lv, Mu, et al.
Publicado: (2022) -
Overexpression of TICRR and PPIF confer poor prognosis in endometrial cancer identified by gene co-expression network analysis
por: Yang, Linlin, et al.
Publicado: (2021) -
Msx1 and Msx2 function together in the regulation of primordial germ cell migration in the mouse
por: Sun, Jingjing, et al.
Publicado: (2016) -
Identification of Genes and Pathways Differentially Expressed in Progestin Responsive Endometrial Cancer and Hyperplasia
por: Gertz, Jay, et al.
Publicado: (2021)